Editor Harold Cohen talks about technology and its effect on pharmacists
FDA Approves Vutrisiran For Adult Patients With ATTR-CM
The decision makes the RNAi therapeutic the only therapy approved by the FDA to treat ATTR-CM and hATTR-PN.
What is Being Done to Address Pharmacy Deserts in the US?
Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.
Pharmacists Play Crucial Role in Counseling, Reporting Adverse Drug Events
National Adverse Drug Event Awareness Day occurs annually on March 24 to raise awareness about minimizing the risk of adverse events caused by medications.
What Does the Future of Pain Medicine Look Like?
With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.
The Power of Pharmacists to Educate, Counsel on OTC Product Use | APhA 2025
Stefanie Ferreri, PharmD, BCACP, FAPhA, discusses literature exploring OTC drugs, supplements, and devices used for non-prescription or self-care purposes.
Diabetes Care in Clinical, Community Pharmacy Practices | APhA 2025
Heather Johnson, PharmD, BCACP, CTTS, and Heather Roth, BSPharm, RPh, compare patients’ diabetes outcomes in clinical and community pharmacy settings.
